Alvotech and Dr Reddy’s Laboratories partner to develop biosimilar for Keytruda targeting global…
Collaboration aims to accelerate development and commercialisation of pembrolizumab biosimilar, expanding access to cancer…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alvotech
Alvotech and Dr Reddy’s collaborate on biosimilar AVT03
Dr Reddy’s gets exclusive commercialisation rights of denosumab in the US as well as semi-exclusive rights in Europe and UK
Alvotech’s AVT05 emerges as leading contender for Simponi biosimilar in rheumatoid arthritis:…
In May 2023, Alvotech and Advanz Pharma announced an extended strategic partnership with plans to supply and commercialise five…
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and…
Cipla has announced that it’s subsidiary, Cipla Gulf is expanding its partnership with Alvotech for the marketing and distribution…
Alvotech in partnership with Cipla Gulf
The partnership will aid in the commercialisation of key biosimilar in select emerging markets